Table 1

Estimated number of genotype 1 HCV patients treated in France in 2010 and 2012 at unchanged screening rate

Treated in 2010*To be treated in 2012
Scenario 1
Total5,10015 000
  • * With PEG-IFN/RBV.

  • With PEG-IFN/RBV+PI with the exception of 10% of treatment-naive, F0-F2 patients who will be treated with PEG-IFN/RBV.